GM just boosted its U.S. manufacturing spend to $6 billion in one year


General Motors has now committed more than $6 billion to U.S. manufacturing in just 12 months—and the latest installment, an $830 million infusion across three propulsion plants announced Wednesday, is starting to look less like a spending spree and more like a strategic homecoming.

The new funding includes flows to Romulus Propulsion Systems in Michigan ($300 million, its second such investment after an identical commitment last year) to expand 10-speed transmission capacity for full-size trucks and SUVs; Toledo Propulsion Systems in Ohio ($40 million, also a second tranche) for light-duty truck transmissions; and Saginaw Metal Casting in Michigan ($150 million) to boost production of heads for sixth-generation V-8 engines destined for next-generation pickups and Corvettes.

In an interview with Fortune, GM’s manufacturing chief Mike Trevorrow said the company made sure the workers heard about it first. UAW representatives joined plant managers on the floor at all three facilities to deliver the news in person. “We were fortunate enough to have them at a couple of our plants today to help with the rollout to the employees,” said Trevorrow, senior vice president of global manufacturing. “It’s fun.”

A century-old idea, quietly revived

The shape of GM’s current manufacturing portfolio—full-size trucks, sixth-generation V-8s, 10-speed transmissions, a broad EV lineup maintained even as battery capacity was trimmed—bears a striking resemblance to a strategy that is literally over 100 years old.

Alfred P. Sloan built GM into the world’s largest automaker in the 1920s through the 1950s on a single organizing idea: offer a vehicle for every person, at every price point, under a stable of distinct brands. He immortalized this with the 1925 advertising slogan, “A car for every purse and purpose.”

When Fortune raised the comparison, Trevorrow paused. “I think it’s always been in our DNA, but I‘ve never heard it referenced specifically.” Then, almost as an aside, he noted: “We have a wide variety of vehicles for everyone.”

The fact that it was Fortune’s question may be the most revealing thing about how GM is operating right now—not as a company consciously invoking its storied past, but as one that has quietly re-internalized it.

‘Fast, flexible, and frugal’

The modern translation of Sloan’s philosophy, in Trevorrow’s telling, is three words: “Fast, flexible, and frugal.” It’s GM’s internal manufacturing mantra, part of CEO Mary Barra’s broader embrace of agility. In an environment where trade policy, consumer demand, and technology are all shifting at once, the ability to pivot is worth more than any single strategic conviction.

That flexibility is why, when EV demand grew more slowly than expected, GM didn’t dismantle its electric vehicle lineup. “We didn’t cut any vehicles,” Trevorrow clarified to Fortune when asked about how this investment reflects the EV focus. “We just cut a little bit of the battery capacity.” The company currently offers more than a dozen EV models and ranks second in U.S. EV sales—while simultaneously pouring hundreds of millions into sixth-generation V-8 infrastructure. Both things coexist, by design.

Trevorrow was careful not to let tariffs take full credit for the investment wave. “Tariffs might be involved only because of the timing,” he said. “When you know the rules, you know the guidelines—how you play that to the benefit of … the country, the consumer, and your company is key.”

What $6 billion looks like on the ground

The roughly 3,000 workers across Romulus, Toledo, and Saginaw are the most concrete expression of what this strategy looks like in practice, and Trevorrow said he thinks GM is in a good place with its workers right now. When asked what changed, he said it’s simple: a lot of surveys.

“We survey our employees,” he said. “In fact, they’ll say we survey too much, and I always say, ‘Remember the time when we didn’t ask?’” Sharing that it’s been in place for a little over five years, and that GM is now in the top quartile of all companies worldwide as a workplace of choice, Trevorrow said, “People like working here. We get that feedback, and we make changes according to it.”

Trevorrow noted this data drives real changes: shift-hour adjustments, lighting improvements on the plant floor, tools designed or 3D-printed based on worker suggestions. “The more we communicate,” he said, “the better we can problem-solve and root-cause things together. That’s the joy, I would say, every day of manufacturing.” GM’s view on continuous improvement, he said, is that everything can be improved.

The manufacturing chief allowed that he’s aware of anxiety, even angst, across the workforce over automation, especially when it comes to artificial intelligence. On AI specifically, he takes the long view. GM has invested more than $250 million over the past five years to upskill workers alongside new technology—setting aside a percentage of every new launch budget to bring plant floor employees up to speed before new automation goes live.

“What I emphasize is we’ve always led in implementation of automation, and we continue to do it,” he said, adding that GM believes in its people. “The investment in bringing our people along on this journey is key. Automation doesn’t work without people … Nothing’s worse than having new automation that sits because nobody knows what to do with it.” The goal isn’t replacement, in his telling. It’s fluency: “We’ll find out how to use our people best, and how to use automation best, and continue to drive both for safety, quality, and efficiency.”

Trevorrow said he sees AI himself daily and describes his own adoption curve in terms that plant workers might recognize. “It takes some getting used to,” he said. “But doesn’t everything? My cell phone took some getting used to. Now, if somebody was to take it away, I would think I’m missing an arm.”

Trevorrow reframed the debate around geopolitical uncertainty, shifting trade patterns, and employee anxiety: “Uncertainty is opportunity, too.”

Free Training

Source link

General Motors invests $6 billion into U.S. manufacturing


DETROIT, Mich. — General Motors has invested over $6 billion into its U.S. manufacturing footprint over the past year, with hundreds of millions dedicated towards projects in Michigan.

The company recently announced $830 million in investments towards projects that will support the launch of GM’s next generation full-size trucks and SUVs.

The sites benefiting from the total investment include:

  • Romulus Propulsion Systems, receiving $300 million to increase the facility’s capacity to produce 10-speed transmissions, which are used in GM’s next-generation full-size trucks and SUVs. This is a further capacity increase for production at Romulus, which initially received $300 million late last year to support this work. Romulus has about 1,000 employees.
  • Saginaw Metal Casting Operations (Michigan) recently announced to its approximately 350 employees a $150 million investment to increase head casting volume for Gen 6 engines, supporting next-generation full-size pickup trucks and Corvettes.

Comment with Bubbles

BE THE FIRST TO COMMENT

The company says these investments show the strength of GM’s current operations and its focus on positioning its U.S. manufacturing base for continued leadership in full-size truck and SUVs segments.

Free Training

Source link

AI drone company Skydio announces $3.5 billion investment in technology race


Artificial intelligence-powered drone manufacturer Skydio on Friday announced a $3.5 billion investment to expand its domestic production and supply chain as the technology race against China intensifies.

The investment, unveiled during a press conference with local law enforcement in Fairfax County, Virginia, will be deployed over the next five years to scale U.S.-based manufacturing, develop critical components, and create thousands of jobs. 

“This is going to go squarely into the U.S. drone ecosystem,” Skydio CEO Adam Bry said, adding that the company plans to “5x the size of our own factory” and dedicate roughly $1 billion toward sourcing key components domestically.

The announcement comes amid heightened warnings from U.S. officials about foreign threats to American innovation. 

A memo circulated this week by White House technology adviser Michael Kratsios warned that China has been actively attempting to steal United States advances in AI, raising concerns about supply chain vulnerabilities.

Bry emphasized that the global drone market has been dominated by foreign manufacturers, many based in China.

“It’s just untenable to be dependent on our adversaries for technology this important,” he said. 

A central component of the investment is a new initiative aimed at “onshoring” production of drone parts, including motors, batteries, and microchips. The effort seeks to build a fully domestic supply chain for robotics and AI-enabled systems, reducing reliance on overseas manufacturing hubs. 

“It’s not a mystery that right now, the world-leading manufacturing ecosystem for electronics is in China,” Bry said. “But there’s no law of physics that says it has to be that way.” 

Bry said the investment will create thousands of jobs, primarily in California, where the company is based, but will also look nationally.

Kratsios, who attended the announcement event, called the announcement “a real turning point” for U.S. industrial policy, tying it to broader federal efforts to secure supply chains and strengthen domestic manufacturing. 

“We are going to ensure that the most advanced, most reliable and most trusted systems in the world are built here in the United States,” he said, describing domestic production as a “national security imperative.” 

Drone technology is increasingly linked to broader geopolitical competition with China, particularly as AI-driven systems become integral to military, infrastructure, and public safety operations. 

Skydio drones are already used by U.S. military branches, law enforcement agencies, and infrastructure operators, driving demand for expanded domestic production.

US MILITARY SITES DEPLOY DRONES FOR SECURITY AS RECRUITMENT FLUCTUATES

President Donald Trump has pushed for what he has dubbed “drone dominance,” signing an executive order that seeks to build a strong domestic drone sector. 

Skydio is already part of the administration’s movement, as it secured a record-breaking contract with the Department of War in March, making a $52 million sale of its drones to the agency, the largest small drone procurement from a single manufacturer.

Free Training

Source link

Skydio to invest $3.5 billion to expand U.S. drone manufacturing


Skydio announced plans to invest $3.5 billion in the United States over the next five years to expand domestic manufacturing and research capabilities. The company said the initiative aims to strengthen supply chains and support long-term growth in the U.S. drone industry.

 

The investment is expected to create more than 2,000 jobs within Skydio and support over 3,000 additional roles across the domestic supply chain. More than $1 billion of the total funding will be directed to U.S.-based suppliers.

Skydio said it already produces more dual-use drones than any company outside China. The company has delivered over 60,000 systems to more than 3,800 customers, including public safety agencies, U.S. military branches, allied nations and commercial operators.

A central element of the expansion is the SkyForge program. This initiative is designed to support domestic production and reinforce U.S.-based manufacturing capabilities.

 

 

The company plans to open a new manufacturing facility that will be five times larger than its current site. This will mark Skydio’s fifth expansion in eight years as it responds to increased demand.

The investment will also support the development of domestic suppliers for critical components. Skydio said it will work with selected partners to co-locate production and provide access to engineering expertise.

Adam Bry, co-founder and Chief Executive Officer of Skydio, said: “U.S. innovation invented the airplane, ramped up manufacturing to win WWII, put a man on the moon, broke the sound barrier, and commercialized space travel.” He added: “Skydio has proven that American companies can compete and win in the civilian drone market against products from our adversaries.”

The company said drones have rapidly evolved into critical infrastructure tools across multiple sectors. Its systems are used in public safety, where aerial capabilities can support faster response times.

 

 

Skydio said its technology enables drones to arrive first at incident scenes in a majority of cases. In some situations, operations can be resolved without deploying additional units.

The company said the investment will reinforce domestic manufacturing of electronics and components. It also aims to strengthen secure supply chains that support national resilience.

Skydio said it will continue expanding production capacity to meet demand from public safety, national security and utility sectors. The company added that the initiative reflects a broader effort to position the United States as a leader in autonomous aerial systems.

 

Free Training

Source link

AbbVie Invests $1.4 Billion into New Manufacturing Campus in North Carolina


AbbVie announced a $1.4 billion investment to build a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina.

Emerging Pharma Leaders nominations are now open!

Do you know someone who can make tough decisions that continue to face manufacturers? Are they destined to change the future of pharma?

Nominate a colleague with impressive leadership and career intentions – even yourself! – for the Pharmaceutical Executive 2026 Emerging Pharma Leaders Awards.

The decision marks the company’s largest capital investment to date and its first major presence in the state.

The campus, located near Research Triangle Park, is set to integrate advanced manufacturing and laboratory technologies with artificial intelligence to support production of AbbVie’s immunology, neuroscience, and oncology medicines.1 The first phase of construction is expected to include small volume parenteral drug product manufacturing facilities for sterile injectables including vials, prefilled cartridges, and prefilled syringes, alongside next-generation laboratories, a warehouse, administrative offices, and employee wellness facilities.1

Upon complete, the Durham campus will serve as AbbVie’s U.S. center of excellence for SVP manufacturing, supplying patients both domestically and internationally.1

Construction begins this year, with completion expected by the end of 2028.

AbbVie is expecting to hire 734 people over the next four years, including engineers, scientists, manufacturing operators, and laboratory technicians, along with the development phase expecting to generate more than 2,000 construction jobs. Durham was selected due to the strength of its regional workforce and its capacity to support future expansion.

“Our investment in North Carolina represents a significant milestone for AbbVie as our largest capital investment to date and an important expansion of our manufacturing footprint into a new region of the United States,” said Robert A. Michael, chairman and chief executive officer of AbbVie. “By establishing this campus, we are strengthening our ability to support future medical breakthroughs while also creating new jobs and a long-term partnership with Durham and the State of North Carolina.”

North Carolina Governor Josh Stein welcomed the investment, saying, “When you combine our world-renowned research and innovation with a strong, thriving life sciences hub, North Carolina quickly becomes the premier location for biopharmaceutical companies to do business.”

The Durham campus is part of AbbVie’s previously announced $100 billion commitment to U.S. research, development, and capital investments over the next decade.2 The company says it has now committed more than $2.2 billion in U.S. manufacturing investment over the past 12 months, including a $745 million license agreement with Haisco, and creating more than 1,300 jobs across North Carolina, Illinois, Arizona, and Massachusetts. AbbVie currently employs approximately 29,000 people in the U.S., including more than 6,000 at its domestic manufacturing campuses.

“AbbVie’s mission is to make a remarkable impact for the patients we serve around the world through our innovative medicines,” said Robert A. Michael, chairman and chief executive officer, AbbVie. “With approximately 29,000 U.S.-based employees and products treating 16 million Americans annually, we understand the complexity and access challenges in our healthcare system.”

The investment follows a broader trend of major pharmaceutical companies expanding U.S. manufacturing capacity, driven by a combination of supply chain resilience concerns, domestic policy incentives, and growing demand for complex biologics and injectable therapies across chronic disease indications.

  1. AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus AbbVie April 22, 2026 https://www.prnewswire.com/news-releases/abbvie-selects-north-carolina-for-new-1-4-billion-manufacturing-campus-302750567.html
  2. AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans AbbVie January 12, 2026 https://news.abbvie.com/2026-01-12-AbbVie-and-Trump-Administration-Reach-Agreement-to-Improve-Access-and-Affordability-for-Americans

Free Training

Source link

Toyota Invests $1 Billion to Expand U.S. Manufacturing Capacity


GEORGETOWN, Ky. — Toyota is investing $1 billion across its Kentucky and Indiana manufacturing operations to expand production capacity and support electrification, as the company marks 40 years of vehicle assembly in Kentucky.

The investment includes $800 million at Toyota’s Georgetown, Kentucky plant to prepare the facility for a second battery electric vehicle and increase assembly capacity for the Camry and RAV4. An additional $200 million will go to Toyota’s Indiana plant to expand production of the Grand Highlander SUV.

Toyota said the investment is part of a previously announced plan to invest up to $10 billion in U.S. manufacturing over the next five years, aimed at meeting customer demand and supporting a broader vehicle lineup.

The Georgetown facility, Toyota’s largest manufacturing plant globally, has produced more than 14 million vehicles since opening in 1986. The site remains a key hub for vehicle assembly and is central to the company’s strategy to expand production in North America.

In Indiana, the investment will increase output of the Grand Highlander, which will be assembled alongside the Sienna minivan in the plant’s East facility while continuing production with the Lexus TX in the West facility.

“Today’s announcement reflects the company’s commitment to meeting customer demand and the belief in our team to get it done,” said Jason Puckett, president of Toyota Indiana.

Toyota said the investments are designed to increase throughput and support production of both traditional and electrified vehicles as demand shifts across the automotive market.

]]>


Looking for quick answers on assembly and manufacturing topics?


Try Ask ASM, our new smart AI search tool.

Ask ASM

In addition to manufacturing expansion, the company is investing in workforce development programs tied to its production operations. Toyota Kentucky announced $4 million in funding for STEM education initiatives in local school systems and $400,000 to support manufacturing engineering programs at Eastern Kentucky University.

The company said the efforts are intended to support workforce readiness and ensure a pipeline of skilled workers for future production needs.

Toyota’s Kentucky plant employs approximately 10,000 workers, while its Indiana facility employs more than 7,000. The company said continued investment in facilities and workforce development is essential to maintaining production capacity and supporting long-term manufacturing growth in the United States.

Free Training

Source link

UCB to Invest $2 Billion in Georgia, Establish First U.S. Manufacturing Facility


Georgia seal

ATLANTA – March 24, 2026 – Governor Brian P. Kemp today announced that global biopharmaceutical giant UCB, Inc. is planning a significant investment of $2 billion in Georgia to establish its first U.S. pharmaceutical biologics manufacturing facility. The investment will generate 330 new jobs over the next several years at the Rowen Foundation’s state-of-the-art, 2,000-acre science and learning campus in Gwinnett County.

“When we met with UCB leadership earlier this year in Belgium, we discussed how the Peach State would be the right partner for their visionary plans in the U.S. that will benefit both patients and hardworking Georgians,” said Governor Brian Kemp. “UCB’s announcement is also a significant milestone for our life sciences industry, representing one of the largest investments in state history and establishing both the Rowen facility and Georgia as a true hub of innovation in this field.”

A global biopharmaceutical company based in Belgium, UCB’s North American headquarters are located in Smyrna and currently support more than 400 jobs. UCB’s expertise spans neurology and immunology.

“This decision reflects our confidence in UCB’s long-term growth and our deep-rooted commitment to the United States,” said Jean-Christophe Tellier, CEO of UCB. “By investing in Georgia, where our U.S. headquarters have been based for more than three decades, we are strengthening our biologics manufacturing capabilities, supporting our innovation pipeline, and creating high-quality jobs in a state that offers outstanding talent, a strong manufacturing tradition, and an ecosystem designed for sustainable, long-term success. This project is expected to generate approximately $5 billion in total economic impact, reflecting the broader value it will create for the region and its communities.”

UCB’s new manufacturing footprint will be located at Rowen, serving as an anchor tenant for this 2,000-acre planned community in metro Atlanta designed to foster collaboration, knowledge sharing, and innovation. The cutting-edge campus will use a digital-first approach by leveraging AI, robotics, and automation while also prioritizing efficiency in the use of any natural resources.  

“We are thrilled that UCB has chosen Gwinnett County to advance its global operations and pioneering innovations,” said Chairwoman Nicole Love Hendrickson, Gwinnett County Board of Commissioners. “An investment of this magnitude was exactly what we envisioned when we committed to establishing Rowen as a hub for collaboration and discovery. As one of the most dynamic and diverse counties in the nation, Gwinnett connects UCB to a highly skilled, globally connected talent pool. UCB’s decision to invest here makes clear what industry leaders increasingly recognize: Gwinnett County is a partner in progress, committed to world-class infrastructure, premier services, and quality of life that support continued growth and success.”

“UCB’s decision to locate their new manufacturing operation in Gwinnett County is a testament to the strength of our entire region to support the growth of the life sciences industry,” said Katie Kirkpatrick, President and CEO of the Metro Atlanta Chamber. “UCB’s innovation, talent, and strategic investment show that metro Atlanta is not just a hub for life sciences today, but a place where the breakthroughs of tomorrow are taking shape.”

Project Director EJane Caraway represented the Georgia Department of Economic Development’s (GDEcD) Global Commerce team on this competitive project in partnership with Partnership Gwinnett, Metro Atlanta Chamber, Georgia Quick Start, and Georgia Power.

“For more than a century, UCB has been a leader in biopharmaceutical innovation,” said GDEcD Commissioner Pat Wilson. “Georgia’s growing life sciences ecosystem and collaborative approach to economic development connect companies with world-class partners in research, education, logistics, and infrastructure. Together with our focus on being the Top State for Talent, it’s why innovators like UCB choose Georgia to advance discoveries from R&D to real-world impact.”

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With approximately 9,000 people in approximately 40 countries, the company generated revenue of €7.7 billion in 2025. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news.

Free Training

Source link

Is CSL’s US$3 Billion US Manufacturing Push Altering The Investment Case For CSL (ASX:CSL)?


  • Earlier this month, CSL broke ground on a major expansion of its Kankakee, Illinois manufacturing facility, aiming to boost plasma-derived therapy and albumin output using its patented Horizon 2 process while adding at least 300 new pharmaceutical roles and about 800 construction jobs.
  • This multiyear U.S. build-out, part of more than US$3.00 billion invested in American operations since 2018, signals CSL’s intention to deepen its U.S. manufacturing base and improve plasma efficiency to support longer-term therapy supply.
  • We’ll now examine how this large-scale U.S. manufacturing expansion, built around CSL’s Horizon 2 technology, could influence the company’s investment narrative.

The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

CSL Investment Narrative Recap

To own CSL, you need to believe its plasma and specialty therapies portfolio can translate operational improvements into healthier margins after a tough stretch of lower profitability and share price underperformance. The Kankakee Horizon 2 expansion supports the longer term efficiency story, but it does not materially change the near term focus on cost control, execution on new product launches, and the risk that rising collection and manufacturing costs keep pressuring margins.

The recent Kankakee expansion update ties most closely to CSL’s broader manufacturing and cost transformation efforts, including the multiyear US$0.5 billion savings program targeting better plasma collection and processing efficiency. Together with initiatives like Horizon 2, these moves sit at the heart of the main positive catalyst for the stock: whether CSL can convert process improvements into sustainably higher gross margins while managing risks from price competition, regulatory shifts and the planned Seqirus demerger.

Yet investors should be aware that rising plasma costs and lower recent profit margins could still weigh on CSL if…

Read the full narrative on CSL (it’s free!)

CSL’s narrative projects $18.1 billion revenue and $4.2 billion earnings by 2028.

Uncover how CSL’s forecasts yield a A$205.16 fair value, a 52% upside to its current price.

Exploring Other Perspectives

ASX:CSL 1-Year Stock Price ChartASX:CSL 1-Year Stock Price Chart

Some of the lowest ranked analysts were assuming only about 2.9 percent annual revenue growth to roughly US$16.9 billion and earnings around US$3.7 billion, which is far more cautious than the consensus and could be challenged or reinforced by how effectively CSL’s Kankakee build and wider efficiency plans actually improve margins over time.

Explore 18 other fair value estimates on CSL – why the stock might be worth over 2x more than the current price!

The Verdict Is Yours

Don’t just follow the ticker – dig into the data and build a conviction that’s truly your own.

Ready For A Different Approach?

Our top stock finds are flying under the radar-for now. Get in early:

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.
It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Free Training

Source link

Japan’s $36 Billion U.S. Investments: A New Era in Energy and Manufacturing


In a major economic development, President Donald Trump’s administration has unveiled three significant projects totaling $36 billion, all financed by Japan. These ventures mark the first wave of investments under Japan’s $550 billion commitment to the United States as part of a trade agreement that reduced tariffs on Japanese imports to 15%.

Among the projects is a $2.1 billion deepwater crude oil export facility in Texas, expected to generate up to $30 billion annually in exports. An $800 million industrial diamonds plant is set for Georgia, aimed at meeting the entire U.S. demand for synthetic diamond grit used in advanced manufacturing. The centerpiece, however, is a $33 billion natural gas-fired power plant in Ohio, slated to become the world’s largest of its kind by capacity.

The announcement follows recent discussions between U.S. Secretary of Commerce Howard Lutnick and Japan’s economic minister, Ryosei Akazawa. While the projects promise significant benefits, key issues, including financial specifics and tariff implications, remain under negotiation as both nations navigate this landmark collaboration.

(With inputs from agencies.)

Free Training

Source link

Siemens Energy to Invest $1 Billion in U.S. Manufacturing, Add 1,500 Jobs



Siemens Energy plans to invest $1 billion to expand U.S. manufacturing capacity for grid equipment and gas turbines, adding more than 1,500 jobs as power demand accelerates from data centers, AI infrastructure and electrification.

(P&GJ) — Siemens Energy has finalized plans to invest $1 billion to expand manufacturing operations across the United States, a move that will create more than 1,500 highly skilled jobs as electricity demand rises sharply due to data centers, artificial intelligence infrastructure and industrial electrification.

The investment builds on plans outlined at the company’s Capital Market Day in Charlotte, North Carolina, last November and includes a mix of brownfield expansions and one greenfield project. Siemens Energy said the program will increase domestic production of grid equipment, transformers and large gas turbines, while strengthening U.S.-based manufacturing capacity to meet growing demand.

As part of the expansion, Siemens Energy will construct a new high-voltage switchgear manufacturing facility in Mississippi and expand transformer production, gas turbine manufacturing and grid technology operations in several states. The company said the approach allows it to use manufacturing capacity efficiently while supporting long-term market growth.

“Siemens Energy has been making things in the United States for more than a century and we are experiencing a once-in-a-generation growth opportunity due to the resurgence of U.S. manufacturing and the growth of artificial intelligence,” said Christian Bruch, CEO and President of Siemens Energy. “The current policy environment has contributed to this momentum. The Trump Administration has made energy security, a reliable and resilient grid, and growing U.S. manufacturing jobs a priority. This has supercharged the energy demand which is supporting new investments across the energy sector. We are excited to help write this next chapter of American energy expansion.”

The expansion is expected to add more than 1,500 roles across manufacturing, engineering and operations. Siemens Energy said it will also expand apprenticeship programs and training initiatives to support workforce development across the energy industry.

“This tremendous investment in a critical part of our power grid supply chain underscores President Trump’s success in expanding supply chain access and bringing major manufacturing back to America,” said U.S. Interior Secretary Doug Burgum. “We appreciate great partners like Siemens Energy, who proactively partner with the Trump administration for the benefit of the American people, prioritizing critical components to make the United States Energy Dominant!”

Planned Site Investments

Siemens Energy said the investment will be spread across multiple states:

  • Mississippi (Greater Richland area): Construction of a new high-voltage switchgear plant, including a training center, with plans to hire up to 300 employees.

  • North Carolina (Charlotte, Winston-Salem and Raleigh): Expanded transformer manufacturing and servicing, resumption of gas turbine manufacturing in Charlotte, turbine component production in Winston-Salem, and expanded grid technology, engineering and R&D operations in Raleigh. About 500 jobs are expected across the state.

  • Florida (Orlando and Tampa): Expansion of turbine blade and vane manufacturing in Tampa and upgrades to research and development capabilities in Orlando, including an artificial intelligence digital grid technologies laboratory with NVIDIA. The company will also relocate and modernize its regional headquarters in Orlando.

  • Alabama (Fort Payne): Expanded production of copper and insulation components for generators, creating about 120 jobs.

  • New York (Painted Post) and Texas (Houston): Facility upgrades supporting the manufacture and servicing of compression equipment used to transport gas and liquids through pipelines.

Siemens Energy said the U.S. remains a core market for the company, accounting for nearly 29% of global order volume last fiscal year. The company currently employs more than 12,000 people across 25 U.S. facilities and works with nearly 5,000 domestic suppliers.

Free Training

Source link